Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Retained Earnings: 2019-2025

Historic Retained Earnings for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$1.7 billion.

  • CureVac N.V's Retained Earnings rose 6.80% to -$1.7 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.7 billion, marking a year-over-year increase of 6.80%. This contributed to the annual value of -$1.5 billion for FY2024, which is 10.97% up from last year.
  • CureVac N.V's Retained Earnings amounted to -$1.7 billion in Q2 2025, which was down 12.01% from -$1.5 billion recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Retained Earnings registered a high of -$1.1 billion during Q2 2021, and its lowest value of -$1.8 billion during Q2 2024.
  • Its 3-year average for Retained Earnings is -$1.6 billion, with a median of -$1.6 billion in 2023.
  • Per our database at Business Quant, CureVac N.V's Retained Earnings slumped by 181,350.41% in 2021 and then rose by 13.86% in 2025.
  • CureVac N.V's Retained Earnings (Quarterly) stood at -$1.2 billion in 2021, then dropped by 10.20% to -$1.3 billion in 2022, then dropped by 26.47% to -$1.7 billion in 2023, then grew by 10.97% to -$1.5 billion in 2024, then grew by 6.80% to -$1.7 billion in 2025.
  • Its Retained Earnings was -$1.7 billion in Q2 2025, compared to -$1.5 billion in Q1 2025 and -$1.5 billion in Q4 2024.